Here, the humoral responses to BNT162b2 were comparable between patients without ARDs and with ARDs treated with MTXM, Cs-DMARDs, TNF-i, JAK-i, and IL6-i. The gene discussed is IL6; the disease is acute respiratory distress syndrome.